Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
44.05
+0.93 (2.15%)
Oct 19, 2026, 10:24 AM EDT - Market open
Veracyte Employees
Veracyte had 755 employees as of December 31, 2025. The number of employees decreased by 69 or -8.37% compared to the previous year. That makes Veracyte the 16,924th largest employer in the world and 2,371st in the United States.
Employees
755
Change (1Y)
-69
Growth (1Y)
-8.37%
Revenue / Employee
$744,238
Profits / Employee
$151,633
Market Cap
3.54B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 755 | -69 | -8.37% |
| Dec 31, 2024 | 824 | 9 | 1.10% |
| Dec 31, 2023 | 815 | 28 | 3.56% |
| Dec 31, 2022 | 787 | 26 | 3.42% |
| Dec 31, 2021 | 761 | 441 | 137.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| RadNet | 9,276 |
| Qiagen | 5,700 |
| Sotera Health Company | 3,000 |
| NeoGenomics | 2,500 |
| GeneDx Holdings | 1,300 |
| GRAIL | 910 |
| CareDx | 765 |
| Adaptive Biotechnologies | 624 |
VCYT News
- 2 hours ago - Six Studies to Highlight Veracyte's Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026 - GlobeNewsWire
- 3 days ago - Veracyte Secures Medicare Reimbursement for Prosigna Breast Risk of Recurrence Test - GlobeNewsWire
- 4 days ago - Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026 - GlobeNewsWire
- 13 days ago - Cathie Wood’s ARK Investment buys 115.5K shares of Veracyte today - TheFly
- 17 days ago - Cathie Wood’s ARK Investment buys 159K shares of Veracyte today - TheFly
- 20 days ago - Veracyte announces new findings from Phase III NRG/RTOG 0815 trial - TheFly
- 20 days ago - Phase III Trial Demonstrates Veracyte's Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation - GlobeNewsWire
- 23 days ago - Veracyte Announces Eight Decipher-Focused Studies to Be Presented at ASTRO 2026 - GlobeNewsWire